from Gimv (EBR:GIMB)
Gimv partners with Ambulantis to support the company's growth ambitions
Press release
Gimv partners with Ambulantis to support the company's growth ambitions
• Gimv invests in the German Ambulantis Group, a fast-growing care provider with a focus on outpatient care in assisted living facilities and day care.
• The company currently employs more than 500 people and operates in 6 cities in northern and eastern Germany, in some cases with multiple locations.
• This transaction is part of a growth plan with the company's founders and managing directors, Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber, continuing to
be key shareholders of the company.
Ambulantis (www.ambulantis.de) is committed to enabling people in need of care to lead a fulfilling life in their own home or shared apartment. To this end, the company offers nursing care including outpatient care, day care, care in assisted living facilities and residential care communities. Its approach enables customers to maintain a high degree of privacy and independence while benefiting from nursing care tailored to their individual needs. In addition, the Ambulantis concept promotes social interaction and participation in society through numerous joint activities.
Ambulantis fosters a value-oriented corporate culture based on appreciation, care and participation. The intensive and diverse engagement of the company's employees leads to a high level of employee satisfaction across all locations.
“We are convinced that Gimv's experience in building and scaling healthcare providers makes it the ideal partner to help us realize the company's growth ambitions and expand Ambulantis' presence in Germany,” declare Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber, Managing Partners of
Ambulantis.
“Ambulantis has a focused and proven concept that serves the preferences of clients and relatives as well as caregivers. Thanks to Ambulantis' clear commitment to quality, its skilled and motivated staff and its highly structured and scalable processes, we are convinced that Ambulantis is the right platform to build a leading provider of comprehensive care services in assisted living facilities in Germany. We are excited to supporting the management and the entire Ambulantis team in realizing their ambitious growth plans, ” explain Philipp v. Hammerstein and Lars Timmer, Partner and Senior Principal specializing in healthcare in the Munich office of Gimv.
Gimv will hold a significant stake in Ambulantis and will support Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber in the further development of the group. The transaction is still subject to the usual regulatory approval and is expected to be completed in the coming weeks.
Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 1
Berlin & Munich (DE) and Antwerp (BE), May 5, 2025, 07:30 CET
Press release
About Gimv
Gimv is a European investment company, listed on Euronext Brussels and a member of the Euronext BEL ESG Index. With over 40 years' experience in private equity, Gimv currently has an investment portfolio of more than EUR 1.7 billion. The portfolio contains around 60 portfolio companies, with combined turnover of EUR 4.0 billion and more than 20,000 employees.
As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial, innovative companies with high growth potential and supports them in their transformation into market leaders. Gimv's five investment platforms are Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities. Each platform works with an experienced team across Gimv’s home markets of Benelux, France and DACH, supported by an extended international network of experts.
Further information on Gimv can be found on www.gimv.com.
For further information please contact:
Philipp v. Hammerstein, Partner Healthcare T +49 89 44 23 275 10 philipp.hammerstein@gimv.com
Kristof Vande Capelle, CFO T +32 3 290 22 17 kristof.vandecapelle@gimv.com
Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 2